» Articles » PMID: 32392758

Trimethylamine N-Oxide in Relation to Cardiometabolic Health-Cause or Effect?

Overview
Journal Nutrients
Date 2020 May 13
PMID 32392758
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Trimethylamine-N-oxide (TMAO) is generated in a microbial-mammalian co-metabolic pathway mainly from the digestion of meat-containing food and dietary quaternary amines such as phosphatidylcholine, choline, betaine, or L-carnitine. Fish intake provides a direct significant source of TMAO. Human observational studies previously reported a positive relationship between plasma TMAO concentrations and cardiometabolic diseases. Discrepancies and inconsistencies of recent investigations and previous studies questioned the role of TMAO in these diseases. Several animal studies reported neutral or even beneficial effects of TMAO or its precursors in cardiovascular disease model systems, supporting the clinically proven beneficial effects of its precursor, L-carnitine, or a sea-food rich diet (naturally containing TMAO) on cardiometabolic health. In this review, we summarize recent preclinical and epidemiological evidence on the effects of TMAO, in order to shed some light on the role of TMAO in cardiometabolic diseases, particularly as related to the microbiome.

Citing Articles

Association between plasma trimethylamine N-oxide and cerebral white matter hyperintensity: a cross-sectional study.

Ji X, Zhang X, Zhang J, Niu S, Xiao H, Chen H Front Aging Neurosci. 2024; 16:1498502.

PMID: 39697484 PMC: 11653083. DOI: 10.3389/fnagi.2024.1498502.


Research progress on the association between TMAO and vascular calcification in patients with chronic kidney disease.

Zhang Y, Huang L, Ou S Ren Fail. 2024; 46(2):2435485.

PMID: 39627031 PMC: 11616764. DOI: 10.1080/0886022X.2024.2435485.


Trimethylamine N-oxide: a meta-organismal axis linking the gut and fibrosis.

Jang J, Capaldi E, Smith T, Verma P, Varga J, Ho K Mol Med. 2024; 30(1):128.

PMID: 39180015 PMC: 11344357. DOI: 10.1186/s10020-024-00895-8.


Plasma trimethylamine N-oxide (TMAO): associations with cognition, neuroimaging, and dementia.

Yaqub A, Vojinovic D, Vernooij M, Slagboom P, Ghanbari M, Beekman M Alzheimers Res Ther. 2024; 16(1):113.

PMID: 38769578 PMC: 11103865. DOI: 10.1186/s13195-024-01480-1.


Trimethylamine N-Oxide Improves Exercise Performance by Reducing Oxidative Stress through Activation of the Nrf2 Signaling Pathway.

Zou H, Zhou Y, Gong L, Huang C, Liu X, Lu R Molecules. 2024; 29(4).

PMID: 38398511 PMC: 10893042. DOI: 10.3390/molecules29040759.


References
1.
Hua X, Su Z, Deng R, Lin J, Li D, Pflugfelder S . Effects of L-carnitine, erythritol and betaine on pro-inflammatory markers in primary human corneal epithelial cells exposed to hyperosmotic stress. Curr Eye Res. 2014; 40(7):657-67. PMC: 4793974. DOI: 10.3109/02713683.2014.957776. View

2.
Mitchell S, Smith R . Trimethylaminuria: the fish malodor syndrome. Drug Metab Dispos. 2001; 29(4 Pt 2):517-21. View

3.
Wilson A, Teft W, Morse B, Choi Y, Woolsey S, DeGorter M . Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel Disease. Dig Dis Sci. 2015; 60(12):3620-30. DOI: 10.1007/s10620-015-3797-3. View

4.
Saklayen M . The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep. 2018; 20(2):12. PMC: 5866840. DOI: 10.1007/s11906-018-0812-z. View

5.
Tang W, Wang Z, Li X, Fan Y, Li D, Wu Y . Increased Trimethylamine N-Oxide Portends High Mortality Risk Independent of Glycemic Control in Patients with Type 2 Diabetes Mellitus. Clin Chem. 2016; 63(1):297-306. PMC: 5659115. DOI: 10.1373/clinchem.2016.263640. View